Hepatitis C in Australia — a role for general practitioners?

To the Editor:

1 East Sydney Doctors, Sydney, NSW
2 Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, Sydney, NSW

Correspondence: db@eastsydneydoctors.com.au

Competing interests:

D Baker has received funding for conferences, research and advisory board membership from Gilead, Bristol-Myers Squibb, AbbVie and Merck.

1. van Driel ML, Lim D, Clark PJ. Hepatitis C in Australia — a role for general practitioners? Med J Aust 2017; 207: 53. <MJA full text>
2. Kirby Institute. Monitoring hepatitis C treatment uptake in Australia: issue 6. Sydney: Kirby Institute, University of New South Wales; 2017. https://kirby.unsw.edu.au/sites/default/files/kirby/report/Monitoring-hep-C-treatment-uptake-in-Australia_Iss6-FEB17.pdf (viewed Dec 2017).

Online responses are no longer available. Please refer to our instructions for authors page for more information.